Ligandal nano-scaffolds will block the virus from binding to ACE2, act as adjuvants to other vaccines, present epitopes for correct B cell receptor and antibody formation, and exhibit T cell receptor epitopes for key immunogenic responses. This is just the start of what we do. 
You could even give these scaffolds to people receiving Moderna’s vaccine, and other vaccines, and the tech is engineered so you would start preferentially generating the correct antibodies for forming a neutralizing response to the virus.
This will also be a therapeutic, which can be given after infection to 1) prevent viral entry, 2) prevent ACE2 coating of the virus, and 3) accentuate antibody responses to the receptor-binding domain of the virus.
